Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiproliferative, proapoptotic, and tumor-suppressing effects of the novel anticancer agent alsevirone in prostate cancer cells and xenografts.
Khan II, Karshieva SS, Sokolova DV, Spirina TS, Zolottsev VA, Latysheva AS, Anisimova NY, Komarova MV, Yakunina MN, Nitetskaya TA, Misharin AY, Pokrovsky VS. Khan II, et al. Arch Pharm (Weinheim). 2022 Jan;355(1):e2100316. doi: 10.1002/ardp.202100316. Epub 2021 Oct 19. Arch Pharm (Weinheim). 2022. PMID: 34668210
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors.
Plyasova AA, Berrino E, Khan II, Veselovsky AV, Pokrovsky VS, Angeli A, Ferraroni M, Supuran CT, Pokrovskaya MV, Alexandrova SS, Gladilina YA, Sokolov NN, Hilal A, Carta F, Zhdanov DD. Plyasova AA, et al. Among authors: khan ii. J Med Chem. 2021 Aug 12;64(15):11432-11444. doi: 10.1021/acs.jmedchem.1c00756. Epub 2021 Jul 20. J Med Chem. 2021. PMID: 34283610
Synthesis and Preclinical Evaluation of Small-Molecule Prostate-Specific Membrane Antigen-Targeted Abiraterone Conjugate.
Machulkin AE, Nimenko EA, Zyk NU, Uspenskaia AA, Smirnova GB, Khan II, Pokrovsky VS, Vaneev AN, Timoshenko RV, Mamed-Nabizade VV, Zavertkina MV, Erofeev A, Gorelkin P, Majouga AG, Zyk NV, Khazanova ES, Beloglazkina EK. Machulkin AE, et al. Among authors: khan ii. Molecules. 2022 Dec 12;27(24):8795. doi: 10.3390/molecules27248795. Molecules. 2022. PMID: 36557929 Free PMC article.
Assessment of the effects of amphiphilic poly (N‑vinylpyrrolidone) nanoparticles loaded with bortezomib on glioblastoma cell lines and zebrafish embryos.
Yagolovich AV, Kuskov AN, Kulikov PP, Bagrov DV, Petrova PA, Kukovyakina EV, Isakova AA, Khan II, Pokrovsky VS, Nosyrev AE, Stamati PC, Markvicheva EA, Gasparian ME, Spandidos DA, Tsatsakis AM. Yagolovich AV, et al. Among authors: khan ii. Biomed Rep. 2024 Jan 17;20(3):37. doi: 10.3892/br.2024.1725. eCollection 2024 Mar. Biomed Rep. 2024. PMID: 38343660 Free PMC article.
Clinical surveillance systems obscure the true cholera infection burden in an endemic region.
Hegde ST, Khan AI, Perez-Saez J, Khan II, Hulse JD, Islam MT, Khan ZH, Ahmed S, Bertuna T, Rashid M, Rashid R, Hossain MZ, Shirin T, Wiens KE, Gurley ES, Bhuiyan TR, Qadri F, Azman AS. Hegde ST, et al. Among authors: khan ii. Nat Med. 2024 Mar;30(3):888-895. doi: 10.1038/s41591-024-02810-4. Epub 2024 Feb 20. Nat Med. 2024. PMID: 38378884 Free PMC article.
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.
Akhtar M, Islam MR, Khaton F, Soltana UH, Jafrin SA, Rahman SIA, Tauheed I, Ahmed T, Khan II, Akter A, Khan ZH, Islam MT, Khanam F, Biswas PK, Ahmmed F, Ahmed S, Rashid MM, Hossain MZ, Alam AN, Alamgir ASM, Rahman M, Ryan ET, Harris JB, LaRocque RC, Flora MS, Chowdhury F, Khan AI, Banu S, Shirin T, Bhuiyan TR, Qadri F. Akhtar M, et al. Among authors: khan ii. Front Immunol. 2023 Dec 20;14:1309997. doi: 10.3389/fimmu.2023.1309997. eCollection 2023. Front Immunol. 2023. PMID: 38173725 Free PMC article.
28 results